3,4-methylenedioxyamphetamine has been researched along with Cerebrovascular Disorders in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Silva, RN | 1 |
| Harries, DP | 1 |
| Grange, SL | 1 |
| Castro, S | 1 |
| Owensby, S | 1 |
| Thorpe, M | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Misuse of ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cerebrovascular Disorders; Designer Drugs; Humans; | 1992 |
Keeping the circle of love alive.
Topics: Adaptation, Psychological; Aged; Cerebrovascular Disorders; Coma; Family; Female; Humans; Love; Pati | 1996 |